索拉非尼
Sorafenib
索拉非尼;4-{4-[3-(4-氯-3-三氟甲基苯基)酰脲]苯氧基}吡啶-2-甲酰胺;对甲苯磺酸索拉非尼;索拉菲尼;索+E51拉尼;索拉非尼碱;索拉替尼;索拉菲尼碱;O-(2-氨乙基)-O`-[2-(BOC-氨乙基]五缩六乙二醇;Sorafenib tosylate 索拉非尼;Sorafenib tosylate 索拉非尼 标准品;甲磺酸索拉非尼;硫酸颠茄碱;索拉非尼、索拉非尼碱、索拉菲尼;索拉非尼-D4;索拉非尼标准品;索拉非尼对甲苯磺酸索拉非尼;索拉非尼杂质;索拉非尼杂质 库存;索拉非尼杂质及标准品;索拉非尼中间体;索拉菲尼标准品及杂质;索拉菲尼杂质;索拉菲尼杂质及标准品;索拉菲尼中间体2;托西酸索拉非尼;Raf抑制剂;舒拉非尼;索拉菲尼单体;索拉替尼  索拉非尼;4-{4-[3-(4-氯-3-三氟甲基苯基)酰脲]苯氧基}吡啶-2-甲酰胺;对甲苯磺酸索拉非尼;索拉菲尼;索+E51拉尼;索拉非尼碱;索拉替尼;索拉菲尼碱;O-(2-氨乙基)-O`-[2-(BOC-氨乙基]五缩六乙二醇;Sorafenib tosylate 索拉非尼;Sorafenib tosylate 索拉非尼 标准品;甲磺酸索拉非尼;硫酸颠茄碱;索拉非尼、索拉非尼碱、索拉菲尼;索拉非尼-D4;索拉非尼标准品;索拉非尼对甲苯磺酸索拉非尼;索拉非尼杂质;索拉非尼杂质 库存;索拉非尼杂质及标准品;索拉非尼中间体;索拉菲尼标准品及杂质;索拉菲尼杂质;索拉菲尼杂质及标准品;索拉菲尼中间体2;托西酸索拉非尼;Raf抑制剂;舒拉非尼;索拉菲尼单体;索拉替尼  展开
284461-73-0
C₂₁H₁₆ClF₃N₄O₃
464.83
中文名称 索拉非尼
中文别名 索拉非尼;4-{4-[3-(4-氯-3-三氟甲基苯基)酰脲]苯氧基}吡啶-2-甲酰胺;对甲苯磺酸索拉非尼;索拉菲尼;索+E51拉尼;索拉非尼碱;索拉替尼;索拉菲尼碱;O-(2-氨乙基)-O`-[2-(BOC-氨乙基]五缩六乙二醇;Sorafenib tosylate 索拉非尼;Sorafenib tosylate 索拉非尼 标准品;甲磺酸索拉非尼;硫酸颠茄碱;索拉非尼、索拉非尼碱、索拉菲尼;索拉非尼-D4;索拉非尼标准品;索拉非尼对甲苯磺酸索拉非尼;索拉非尼杂质;索拉非尼杂质 库存;索拉非尼杂质及标准品;索拉非尼中间体;索拉菲尼标准品及杂质;索拉菲尼杂质;索拉菲尼杂质及标准品;索拉菲尼中间体2;托西酸索拉非尼;Raf抑制剂;舒拉非尼;索拉菲尼单体;索拉替尼 
英文名称 Sorafenib
英文别名 Sorafenib tosylate;sorafenib;SORAFENIB-D3;SORAFENIB TOLSYLATE;RAF1 KINASE INHIBITOR II;N-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)-((4-(2-(N-METHYL-CARBAMOYL)(4-PYRIDYLOXY))PHENYL)AMINO)CARBOXAMIDE;4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-n-methyl-pyridine-2-carboxamide;BAY 43-9006;SORAFENIB MESYLATE;BAY-43-9006;Sorafenib (BAY 43-9006);Sorafenib base;Sorafenib Free Base;Epirubicin HCl; 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide;BAY-43-900;Forafenib;Nexavar;4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide;N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea;4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy;4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide;4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy;Q-201728;4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)-amino]phenoxy}-N-methylpyridine-2-carboxamide;SORAFENIB [MART.];N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4- pyridyloxy)phenyl)urea;BS164413;NSC800934;AB00933189_08;4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-picolinamide;tosylic acid;BRD-K23984367-001-01-8;284461-73-0;4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N(sup 2)- methylpyridine-2-carboxamide;4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N(sup 2)- methylpyridine-2-carboxamide;GTPL5711;GTPL5711;AC-1674;AC-1674;BCPP000064;BCPP000064;SF-0529;SF-0529;SR-00000000529;SR-00000000529;4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)phenoxy)-N-methylpyridine-2-carboxamide;4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)phenoxy)-N-methylpyridine-2-carboxamide;4-(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N2-methylpyridine-2-carboxamide;4-(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N2-methylpyridine-2-carboxamide;4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide;4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide;HMS3244B15;HMS3244B15;4-(4-{3-[4-chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)- N-methylpyridine-2-carboxamide;4-(4-{3-[4-chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)- N-methylpyridine-2-carboxamide;NSC-800934;NSC-800934;HMS3244A15;HMS3244A15;UNII-9ZOQ3TZI87;UNII-9ZOQ3TZI87;L01XE05;L01XE05;SW202562-4;SW202562-4;Sorafenib (D3); CM-4307; CM 4307; CM4307;Bay 43-9006 (D3);Sorafenib (D3); CM-4307; CM 4307; CM4307;Bay 43-9006 (D3);NCGC00167488-03;NCGC00167488-03;CS-1590;CS-1590;NCGC00167488-04;NCGC00167488-04;NS00005946;NS00005946;4-(4-(3-(4-C...
CAS No. 284461-73-0
分子式 C₂₁H₁₆ClF₃N₄O₃
分子量 464.83
象形图
警示语
Class
警告声明
UNub
危险声明
Packing Group
搜索质检报告(COA)
搜索MSDS